An $8 million clinical trial of a mitochondrial enhancer, no less, in ME/CFS? I thought I was hearing things but it was so, and, in the end, it even makes sense given how rapidly some parts of this field are moving forward. But first, a little backstory. A...
Frustrated for 10 years in his desire to study ME/CFS, Paul Fisher of LaTrobe University in Australia made the most of it when he got the chance He and his lead researcher on these studies, Daniel Missailidis, have rolled off four studies and two reviews in the last...
It took a muscle biopsy to uncover it but there it was – strong evidence, apparently, of a bona fide mitochondrial deficiency in some people with fibromyalgia (FM). Julian Ambrus, the senior author of this paper has published widely in and developed an animal...
The title of this metabolomic study “Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome” made it clear that something new was in the works. Peroxisomal dysfunction had...
Chris Armstrong PhD (biochemistry and molecular biology) was there at the beginning of the metabolomics field in chronic fatigue syndrome (ME/CFS). In fact, Armstrong was the lead author of the first ME/CFS metabolomics study published in 2012. I asked him how he got...
The overviews of the 2021 IACFS/ME Conference continue with a focus on exercise studies. “A Huge Problem and Major Crisis”: Avindra Nath on Long COVID at the IACFS/ME 2021 Conference “Emerging Options for Autoimmune ME/CFS”: Scheibenbogen at...
